Laboratory Medicine banner
HomeFaculty › David Wu, MD, PhD

David Wu, MD, PhD

photo Dr. David Wu

Associate Professor
Associate Director, UW Hematopathology
Program Director, UW Molecular Genetic Pathology Fellowship

Contact Information

University of Washington
Department of Laboratory Medicine, NW120
Hematopathology Laboratory
825 Eastlake, G7800
Seattle, WA 98115
Tel: 206.288.7060
Fax: 206.288.7127

Personal Biography

Dr. Wu enjoys reading, running, and spending time with friends and family.

Education and Training

  • BS, Chemical Engineering and Biochemistry, University of Illinois, Urbana-Champaign, IL, 1995
  • PhD, Medical Engineering and Medical Physics, Harvard University and Massachusetts Institute of Technology, Cambridge, MA, 2001
  • MD, Harvard Medical School, Boston, MA, 2003
  • Anatomic Pathology, PGY-1 and -2, Brigham and Women's Hospital, Boston, MA, 2003-05
  • Molecular Genetic Pathology, Clinical Fellow, Harvard Medical School, Boston, MA, 2006
  • Anatomic Pathology, PGY-3, Brigham and Women's Hospital, Boston, MA, 2006-07
  • Hematopathology, Clinical Fellow, Brigham and Women's Hospital, Boston, MA, 2007-08

Clinical and Research Interests

  • Hematopathology
  • Solid tumors
  • Molecular pathology
  • Personalized medicine
  • Next-generation sequencing

Current Research

  • Discovery of novel diagnostic markers of hematopoietic neoplasms for diagnostic applications
  • Development, validation and clinical application of next-generation sequencing technologies for diagnosis and prognostication

Selected Publications

  1. Salipante SJ, Fromm JR, Shendure J, Wood BL, Wu D. "Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing." Mod Pathol. 2014 Nov;27(11):1438-46. doi: 10.1038/modpathol.2014.57. Epub (2014).
  2. Wu D, Emerson RO, Sherwood A, Loh ML, Angiolillo A, Howie B, Vogt J, Rieder M, Kirsch I, Carlson C, Williamson D, Wood BL, Robins H. "Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH." Clin Cancer Res. 2014 Sep 1;20(17):4540-8. doi: 10.1158/1078-0432.CCR-13-3231. Epub (2014).
  3. D. Wu, A. Sherwood, J.R. Fromm, S.S. Winter, K.P. Dunsmore, M.L Loh, H.A. Greisman, D.E. Sabath, B.L. Wood and H. Robins, "High-throughput sequencing to detect minimal residual disease in Acute T lymphoblastic leukemia," Science Translational Medicine, 4, 123ra63 (2012).
  4. D. Wu, B. Wood, and J. Fromm, "'Double-hit' mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression," American Journal of Clinical Pathology, 134:258-265, (2010).
  5. D. Wu, Q. Vu, A. Nguyen, J.R. Stone, H. Stubbs, G. Kuhlmann, L.M. Sholl and A.J. Iafrate, "In situ genetic analysis of cellular chimerism, "Nature Medicine, 15(2):215-219, (2009).

Honors and Awards

  • Stanley L. Robbins Memorial Research Award, Dept. of Pathology, Brigham and Women's Hospital, Boston, MA, 2007
  • Young Investigator Award, Association for Molecular Pathology, Annual Meeting, Orlando, FL, 2006
  • Ratheon Company Research Fellow, 2002-2003
  • Whitaker Foundation Graduate Fellow, 1996-2001
  • Tau Beta Pi and Phi Beta Kappa, 1995
  • Harvey H. Jordan Award – Valedictorian, College of Engineering, Univ. of Illinois, Urbana-Champaign, 1995
  • National Science Foundation Graduate Fellowship, National Institutes of Health, Medical Scientist Training Program Fellowship at Northwestern University, Chicago, IL and Washington University, St. Louis, MO.
  • M.D./Ph.D. Fellowship at University of Minnesota, MN; (all declined), 1995
  • Barry M. Goldwater National Scholarship, 3M Engineering Scholar, and International Paper Company Chemical Sciences Scholarship, 1994
  • Colgate-Palmolive Scholar and General Mills, Inc. Scholarship, 1993
  • Illinois General Assembly Scholarship, 1991

Last updated: 1/07/2015

HomeFaculty › David Wu, MD, PhD

Return to Top